secondary malignant neoplasm of skin of head 相关文献:
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N, Bui BN, Bay JO, Cupissol D, Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S, Jimenez M, Isambert N, Peyrade F, Chevreau C, Bompas E, Brain EG, Blay JY.
Malignant melanoma of the skin of the head and neck. An analysis of 405 cases.
Ballantyne AJ.
Am J Surg. 1970 Oct;120(4):425-31. doi: 10.1016/s0002-9610(70)80001-0.
PMID:5507326
[Lymphatic metastases in the parotid region from malignant skin neoplasm of the head: considerations for surgical treatment based on personal clinical experience].
Tullio A, Bianchi B, Sesenna E.
Acta Otorhinolaryngol Ital. 2001 Feb;21(1):44-9.
PMID:11434222
Management of regional metastatic disease in head and neck cutaneous malignancy. 2. Cutaneous malignant melanoma.
Multimodal AI and tumour microenvironment integration predicts metastasis in cutaneous melanoma.
Andrew TW, Combalia M, Hernandez C, Grant S, Paragh G, Puig S, Mc Arthur G, Richardson G, Sloan P, Shalhout SZ, Plummer R, Lovat PE.
Nat Commun. 2025 Nov 18;16(1):10095. doi: 10.1038/s41467-025-65051-0.
PMID:41253792
Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group.
Ringborg U, Afzelius LE, Lagerlöf B, Adami HO, Augustsson I, Blomqvist E, Boeryd B, Carlin E, Edström S, Eldh J, et al.
Cancer. 1993 Feb 1;71(3):751-8. doi: 10.1002/1097-0142(19930201)71:3<751::aid-cncr2820710317>3.0.co;2-9.